174 related articles for article (PubMed ID: 21034493)
1. Gene expression analysis of cell death induction by taurolidine in different malignant cell lines.
Chromik AM; Hahn SA; Daigeler A; Flier A; Bulut D; May C; Harati K; Roschinsky J; Sülberg D; Weyhe D; Mittelkötter U; Uhl W
BMC Cancer; 2010 Oct; 10():595. PubMed ID: 21034493
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.
Chromik AM; Daigeler A; Bulut D; Flier A; May C; Harati K; Roschinsky J; Sülberg D; Ritter PR; Mittelkötter U; Hahn SA; Uhl W
J Exp Clin Cancer Res; 2010 Mar; 29(1):21. PubMed ID: 20205945
[TBL] [Abstract][Full Text] [Related]
3. Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma.
Karlisch C; Harati K; Chromik AM; Bulut D; Klein-Hitpass L; Goertz O; Hirsch T; Lehnhardt M; Uhl W; Daigeler A
Int J Oncol; 2013 Mar; 42(3):945-56. PubMed ID: 23338823
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.
Li F; Qi J; Qin C; Fu Z; Ren W
Oncol Rep; 2018 Dec; 40(6):3743-3751. PubMed ID: 30272302
[TBL] [Abstract][Full Text] [Related]
5. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.
Daigeler A; Brenzel C; Bulut D; Geisler A; Hilgert C; Lehnhardt M; Steinau HU; Flier A; Steinstraesser L; Klein-Hitpass L; Mittelkötter U; Uhl W; Chromik AM
J Exp Clin Cancer Res; 2008 Dec; 27(1):82. PubMed ID: 19077262
[TBL] [Abstract][Full Text] [Related]
6. Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines.
Hotz B; Erben U; Arndt M; Buhr HJ; Hotz HG
Int J Colorectal Dis; 2014 Nov; 29(11):1339-48. PubMed ID: 25179425
[TBL] [Abstract][Full Text] [Related]
7. Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus.
Daigeler A; Chromik AM; Geisler A; Bulut D; Hilgert C; Krieg A; Klein-Hitpass L; Lehnhardt M; Uhl W; Mittelkötter U
Int J Oncol; 2008 Jun; 32(6):1205-20. PubMed ID: 18497982
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells.
Chromik AM; Daigeler A; Hilgert C; Bulut D; Geisler A; Liu V; Otte JM; Uhl W; Mittelkötter U
J Invest Surg; 2007; 20(6):339-48. PubMed ID: 18097875
[TBL] [Abstract][Full Text] [Related]
9. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
[TBL] [Abstract][Full Text] [Related]
10. Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.
Swift L; Zhang C; Kovalchuk O; Boklan J; Trippett T; Narendran A
Invest New Drugs; 2020 Jun; 38(3):690-699. PubMed ID: 31264069
[TBL] [Abstract][Full Text] [Related]
11. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
Nici L; Monfils B; Calabresi P
Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
[TBL] [Abstract][Full Text] [Related]
13. Taurolidine--a new drug with anti-tumor and anti-angiogenic effects.
Jacobi CA; Menenakos C; Braumann C
Anticancer Drugs; 2005 Oct; 16(9):917-21. PubMed ID: 16162968
[TBL] [Abstract][Full Text] [Related]
14. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
[TBL] [Abstract][Full Text] [Related]
15. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma.
Daigeler A; Chromik AM; Haendschke K; Emmelmann S; Siepmann M; Hensel K; Schmitz G; Klein-Hitpass L; Steinau HU; Lehnhardt M; Hauser J
Ultrasound Med Biol; 2010 Nov; 36(11):1893-906. PubMed ID: 20870344
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P
Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956
[TBL] [Abstract][Full Text] [Related]
18. The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism.
Han Z; Ribbizi I; Pantazis P; Wyche J; Darnowski J; Calabresi P
Anticancer Res; 2002; 22(4):1959-64. PubMed ID: 12174870
[TBL] [Abstract][Full Text] [Related]
19. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
20. [In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].
Petrovic L; Schlegel KA; Ries J; Park J; Diebel E; Schultze-Mosgau S; Wiltfang J
Mund Kiefer Gesichtschir; 2003 Mar; 7(2):102-7. PubMed ID: 12664255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
